Dr Abdulgadir Khalifa Adam, MD | |
3535 W 13 Mile Rd Ste 344, Royal Oak, MI 48073-6770 | |
(248) 551-0497 | |
(248) 551-4556 |
Full Name | Dr Abdulgadir Khalifa Adam |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 29 Years |
Location | 3535 W 13 Mile Rd Ste 344, Royal Oak, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942493838 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 4301076176 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
Beaumont Hospital - Farmington Hills | Farmington hills, MI | Hospital |
Beaumont Hospital, Troy | Troy, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beaumont Medical Group- Specialty Services | 7214299866 | 787 |
News Archive
An HIV/AIDS treatment and prevention program in Iran founded by two local physicians is providing antiretroviral drugs and clean needles to HIV-positive people in the country, the Washington Post reports.
Research reveals that most individuals with cancer have religious and spiritual beliefs, or derive comfort from religious and spiritual experiences. But what impact does this have on patients' health? Recent analyses of all published studies on the topic-which included more than 44,000 patients-shed new light on the associations of religion and spirituality with cancer patients' mental, social, and physical well-being.
The Biotechnology Industry Organization invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers, and posters for the 2010 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 11-14, 2010 in Honolulu.
Orthopaedic surgeons face a steep learning curve to get used to new prostheses, and the instruments and methods that go with them, before new total knee replacement procedures are as safe and effective as conventional methods. Patients who undergo the first 15 operations using a new device in a hospital are 48 percent more likely to need early revision surgery, than patients undergoing an operation to fit a prosthesis previously used in the hospital.
Neurologix, Inc. announced the presentation today of efficacy results through one year of follow-up in patients treated as part of the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease.
› Verified 4 days ago
Entity Name | William Beaumont Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083833875 PECOS PAC ID: 9335051093 Enrollment ID: O20031104000279 |
News Archive
An HIV/AIDS treatment and prevention program in Iran founded by two local physicians is providing antiretroviral drugs and clean needles to HIV-positive people in the country, the Washington Post reports.
Research reveals that most individuals with cancer have religious and spiritual beliefs, or derive comfort from religious and spiritual experiences. But what impact does this have on patients' health? Recent analyses of all published studies on the topic-which included more than 44,000 patients-shed new light on the associations of religion and spirituality with cancer patients' mental, social, and physical well-being.
The Biotechnology Industry Organization invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers, and posters for the 2010 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 11-14, 2010 in Honolulu.
Orthopaedic surgeons face a steep learning curve to get used to new prostheses, and the instruments and methods that go with them, before new total knee replacement procedures are as safe and effective as conventional methods. Patients who undergo the first 15 operations using a new device in a hospital are 48 percent more likely to need early revision surgery, than patients undergoing an operation to fit a prosthesis previously used in the hospital.
Neurologix, Inc. announced the presentation today of efficacy results through one year of follow-up in patients treated as part of the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease.
› Verified 4 days ago
Entity Name | Beaumont Medical Group- Specialty Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
An HIV/AIDS treatment and prevention program in Iran founded by two local physicians is providing antiretroviral drugs and clean needles to HIV-positive people in the country, the Washington Post reports.
Research reveals that most individuals with cancer have religious and spiritual beliefs, or derive comfort from religious and spiritual experiences. But what impact does this have on patients' health? Recent analyses of all published studies on the topic-which included more than 44,000 patients-shed new light on the associations of religion and spirituality with cancer patients' mental, social, and physical well-being.
The Biotechnology Industry Organization invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers, and posters for the 2010 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 11-14, 2010 in Honolulu.
Orthopaedic surgeons face a steep learning curve to get used to new prostheses, and the instruments and methods that go with them, before new total knee replacement procedures are as safe and effective as conventional methods. Patients who undergo the first 15 operations using a new device in a hospital are 48 percent more likely to need early revision surgery, than patients undergoing an operation to fit a prosthesis previously used in the hospital.
Neurologix, Inc. announced the presentation today of efficacy results through one year of follow-up in patients treated as part of the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Abdulgadir Khalifa Adam, MD 26901 Beaumont Blvd Ste 3d, Southfield, MI 48033-3849 Ph: () - | Dr Abdulgadir Khalifa Adam, MD 3535 W 13 Mile Rd Ste 344, Royal Oak, MI 48073-6770 Ph: (248) 551-0497 |
News Archive
An HIV/AIDS treatment and prevention program in Iran founded by two local physicians is providing antiretroviral drugs and clean needles to HIV-positive people in the country, the Washington Post reports.
Research reveals that most individuals with cancer have religious and spiritual beliefs, or derive comfort from religious and spiritual experiences. But what impact does this have on patients' health? Recent analyses of all published studies on the topic-which included more than 44,000 patients-shed new light on the associations of religion and spirituality with cancer patients' mental, social, and physical well-being.
The Biotechnology Industry Organization invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers, and posters for the 2010 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 11-14, 2010 in Honolulu.
Orthopaedic surgeons face a steep learning curve to get used to new prostheses, and the instruments and methods that go with them, before new total knee replacement procedures are as safe and effective as conventional methods. Patients who undergo the first 15 operations using a new device in a hospital are 48 percent more likely to need early revision surgery, than patients undergoing an operation to fit a prosthesis previously used in the hospital.
Neurologix, Inc. announced the presentation today of efficacy results through one year of follow-up in patients treated as part of the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease.
› Verified 4 days ago
Nicole Marijanovich, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7999 Fax: 248-898-0580 | |
Vinayata Manuballa Kareti, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 661-948-0803 | |
Filip Ionescu, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-3000 | |
Christopher Carpenter, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3535 W 13 Mile Rd Ste 605, Royal Oak, MI 48073 Phone: 248-551-0495 | |
Dr. Matthew Burns Cotant, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3577 W 13 Mile Rd, Suite 404, Royal Oak, MI 48073 Phone: 248-551-6900 Fax: 248-551-6909 | |
Geoffrey Prysak, MD, MPH Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7999 | |
Taylor Schoenheit, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 |